Network News
-
Subsolid pulmonary nodules: From guidelines to real-world practice
The heterogeneity of guidelines on subsolid pulmonary nodules is likely a contributing factor to the discrepancy between published recommendations and real-world practice, but most societies still prioritize nodule size, development of solid component, and change over time.
-
Riot medicine: Treating injuries from nonlethal force
At this CHEST 2026 session, a panel of experts will review the most common injury patterns seen in riot medicine and describe the most contemporary approach to their management.
-
Impossible choices: Goal-concordant care in the ICU
Clinicians should approach discussions about goal-concordant care with curiosity, humility, and responsibility, for the benefit of both the patient and their family.
-
Recognizing OSA in women: The peri-operative opportunity
OSA in women continues to be underrecognized because it often presents differently than the classic OSA phenotype that has shaped clinical recognition for decades.
-
Seeing the target, missing the risk? Radiation safety in advanced bronchoscopy
While patient exposure receives most of the attention when it comes to radiation risk, careful consideration must be given to the proceduralists and staff who are in the room day after day.
-
Positive results from TETON-1 trial introduce potential new therapy for IPF
Positive results from the TETON trials and expanding treatment options are encouraging for pulmonologists who are used to working with a limited toolkit for slowing disease progression in their patients with IPF.
-
Ventilatory management of immune checkpoint inhibitor pneumonitis
As immune checkpoint inhibitor use continues to expand, prospective data on phenotype-guided management and extracorporeal membrane oxygenation selection criteria are urgently needed.
-
Steroids in pneumonia: The end of an era?
Emerging data suggest a potential expanding role for corticosteroids in severe cases of community-acquired pneumonia, though it remains uncertain whether this approach should extend to nonsevere or outpatient settings.
-
Mucus plugging in severe asthma: Clinical significance and emerging therapeutic targets
As image-based markers become increasingly integrated into severe asthma phenotyping, the mucus plug score may evolve into a clinically actionable tool.
-
Orexin receptor agonists: The evolution of precision medicine in narcolepsy type 1
This kind of therapy represents a promising and exciting step toward a precision medicine approach that directly targets the underlying deficiency of orexin signaling in narcolepsy type 1.
